Exagen outlines $70M-$73M 2026 revenue target while expanding sales force and innovation cadence
Source: SeekingAlpha
2026-03-10 18:50:50 ET
More on Exagen
- Exagen Inc. (XGN) Q4 2025 Earnings Call Transcript
- Quant snapshot: Avino Silver & Gold, Harmony Gold lead strong buys as Angel Studios, Exagen lag
- Seeking Alpha’s Quant Rating on Exagen
- Historical earnings data for Exagen
- Financial information for Exagen
Read the full article on Seeking Alpha
For further details see:
Exagen outlines $70M–$73M 2026 revenue target while expanding sales force and innovation cadence
Exagen Inc.
NASDAQ: XGN
XGN Trading
-0.65% G/L:
$2.86 Last:
57,167 Volume:
$2.85 Open:
XGN Latest News
February 24, 2026 09:00:00 am
Exagen Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026
XGN Stock Data
$80,000,739
13,869,817
3.15%
15
N/A
Medical Diagnostics & Screening
Healthcare
US
Vista
